Recent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk localized, muscle-invasive disease, according to an editorial published in ...

MELBOURNE, Australia and OXFORD, United Kingdom, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Aravax, a clinical-stage biotechnology company developing ...

In a report released yesterday, Madison Elsaadi from B.Riley Financial reiterated a Buy rating on Wave Life Sciences (WVE – Research ...

Anatara Lifesciences Ltd (AU:ANR) has released an update. Anatara Lifesciences is advancing its Phase II trial for GaRP in treating Irritable ...

Researchers advance CAR T cell therapy for solid tumors by innovating ways to overcome the unique barriers of solid tumor ...

Wells Fargo analyst Tiago Fauth maintained a Buy rating on Wave Life Sciences (WVE – Research Report) yesterday and set a price target of $22.00. Tiago Fauth has given his Buy rating due to a ...

RBC Capital analyst Luca Issi maintained a Hold rating on Wave Life Sciences (WVE – Research Report) yesterday and set a price target of $15.00. The company’s shares closed yesterday at $15.89. Issi ...

(Bloomberg) -- Neuralink Corp., Elon Musk’s brain-computer venture, and rivals like Science Corp. are making strides in ...

Professor Nancy Ip discusses her groundbreaking neuroscience research, focusing on neurotrophic factors and innovative ...

Wave Life Sciences Pte. Ltd ( (WVE) ) has released its Q3 earnings. Here is a breakdown of the information Wave Life Sciences Pte. Ltd ...

This initiative is part of CDW’s strategy to diversify and tap into the promising life sciences market. For further insights into SG:BXE stock, check out TipRanks’ Stock Analysis page. Trending ...

Researchers developed MassiveFold, an enhanced AlphaFold version optimized for parallel processing, which accelerates protein ...